Fennec Pharmaceuticals (FENC) Operating Income Growth (1y) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 80.62% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 1.27% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.65% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,386.07% |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | 336.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 336.94% |
| Sep 30, 2025 | 96.37% |
| Jun 30, 2025 | 45.78% |
| Mar 31, 2025 | -105.88% |
| Dec 31, 2024 | 48.62% |
| Sep 30, 2024 | -411.50% |
| Jun 30, 2024 | -7.99% |
| Mar 31, 2024 | 360.78% |
| Dec 31, 2023 | 70.37% |
| Sep 30, 2023 | 87.12% |
| Jun 30, 2023 | 6.85% |
| Mar 31, 2023 | -48.62% |
| Dec 31, 2022 | -45.83% |
| Sep 30, 2022 | -89.29% |
| Jun 30, 2022 | -27.78% |
| Mar 31, 2022 | 27.97% |
| Dec 31, 2021 | -25.73% |
| Sep 30, 2021 | 28.78% |
| Jun 30, 2021 | 19.09% |
| Mar 31, 2021 | -28.37% |
| Dec 31, 2020 | 8.40% |
| Sep 30, 2020 | -214.49% |
| Jun 30, 2020 | -0.66% |
| Mar 31, 2020 | -43.10% |
| Dec 31, 2019 | -17.65% |
| Sep 30, 2019 | 34.59% |
| Jun 30, 2019 | -80.60% |
| Mar 31, 2019 | -49.64% |
| Dec 31, 2018 | -23.46% |
| Sep 30, 2018 | -30.28% |
| Jun 30, 2018 | -80.19% |
| Mar 31, 2018 | -132.30% |
| Dec 31, 2017 | -119.46% |
| Sep 30, 2017 | -287.59% |
| Jun 30, 2017 | -109.19% |
| Mar 31, 2017 | -69.82% |
| Dec 31, 2016 | -107.99% |
| Sep 30, 2016 | -66.86% |
| Jun 30, 2016 | -28.78% |
| Mar 31, 2016 | -0.44% |
| Dec 31, 2015 | 30.34% |
| Sep 30, 2015 | 45.40% |
| Jun 30, 2015 | 40.97% |
| Mar 31, 2015 | 15.83% |
| Dec 31, 2014 | -90.14% |
| Sep 30, 2014 | -1,113.73% |
| Jun 30, 2014 | -0.32% |
| Mar 31, 2014 | 0.00% |
| Dec 31, 2013 | 62.96% |
| Sep 30, 2013 | 91.90% |
| Jun 30, 2013 | 25.84% |
| Mar 31, 2013 | 12.82% |
| Dec 31, 2012 | -24.50% |
| Sep 30, 2012 | 33.26% |
| Jun 30, 2012 | -118.53% |
| Mar 31, 2012 | 39.67% |
| Dec 31, 2011 | -10.54% |
| Sep 30, 2011 | -2.94% |
| Jun 30, 2011 | 77.17% |